Cargando…

Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization

BACKGROUND: The inclusion of immune checkpoint inhibitors (ICIs) in therapeutic algorithms has led to significant survival benefits in patients with various metastatic cancers. Concurrently, an increasing number of neurological immune related adverse events (IRAE) has been observed. In this retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urban, Hans, Steidl, Eike, Hattingen, Elke, Filipski, Katharina, Meissner, Markus, Sebastian, Martin, Koch, Agnes, Strzelczyk, Adam, Forster, Marie-Thérèse, Baumgarten, Peter, Ronellenfitsch, Michael W., Steinbach, Joachim P., Voss, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761630/ https://www.ncbi.nlm.nih.gov/pubmed/35046955 http://dx.doi.org/10.3389/fimmu.2021.798811

Ejemplares similares

Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma
por: Steidl, Eike, et al.
Publicado: (2023)

Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients
por: Zeiner, Pia S., et al.
Publicado: (2019)

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A (1)H-Magnetic Resonance Spectroscopy Study
por: Steidl, Eike, et al.
Publicado: (2016)

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
por: Steidl, Eike, et al.
Publicado: (2021)

Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab
por: Voss, Martin, et al.
Publicado: (2019)

Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition
por: Urban, Hans, et al.
Publicado: (2020)

A Paravermal Trans-Cerebellar Approach to the Posterior Fossa Tumor Causes Hypertrophic Olivary Degeneration by Dentate Nucleus Injury
por: Schaller-Paule, Martin A., et al.
Publicado: (2021)

Single-shot bevacizumab for cerebral radiation injury
por: Voss, Martin, et al.
Publicado: (2021)

Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma
por: Divé, Iris, et al.
Publicado: (2023)

The Acute Superficial Siderosis Syndrome — Clinical Entity, Imaging Findings, and Histopathology
por: Friedauer, Lucie, et al.
Publicado: (2022)

Sequential implementation of DSC-MR perfusion and dynamic [(18)F]FET PET allows efficient differentiation of glioma progression from treatment-related changes
por: Steidl, Eike, et al.
Publicado: (2020)

Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
por: Zeyen, Thomas, et al.
Publicado: (2023)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
por: Zeyen, Thomas, et al.
Publicado: (2023)

MRI characteristics in treatment for cerebral melanoma metastasis using stereotactic radiosurgery and concomitant checkpoint inhibitors or targeted therapeutics
por: Rauch, Maximilian, et al.
Publicado: (2021)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis
por: Luger, Anna-Luisa, et al.
Publicado: (2022)

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial
por: Voss, Martin, et al.
Publicado: (2021)

Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma
por: Kebir, Sied, et al.
Publicado: (2016)

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors
por: Mönch, Sebastian, et al.
Publicado: (2023)

Concurrent CNS tumors and multiple sclerosis: retrospective single-center cohort study and lessons for the clinical management
por: Yalachkov, Yavor, et al.
Publicado: (2022)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis—A Case Series of Three Patients
por: Koch, Agnes, et al.
Publicado: (2022)

Meningioma Surgery in Patients ≥70 Years of Age: Clinical Outcome and Validation of the SKALE Score
por: Monden, Daniel, et al.
Publicado: (2021)

Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas
por: Filipski, Katharina, et al.
Publicado: (2019)

Pseudoprogression Disease in a Patient with Small Cell Lung Cancer on Immune Checkpoint Inhibitor Therapy
por: Zhu, Wanshan, et al.
Publicado: (2023)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Qualitative and quantitative detectability of hypertrophic olivary degeneration in T2, FLAIR, PD, and DTI: A prospective MRI study
por: Steidl, Eike, et al.
Publicado: (2022)

Incidence of Immune-Mediated Pseudoprogression of Lymphoma Treated with Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis
por: Lee, Amy Junghyun, et al.
Publicado: (2021)

Neurocognitive Outcome and Seizure Freedom After Awake Surgery of Gliomas
por: Reitz, Sarah Christina, et al.
Publicado: (2022)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet
por: Voss, Martin, et al.
Publicado: (2018)

Topographic Mapping of Isolated Thalamic Infarcts Using Vascular and Novel Probabilistic Functional Thalamic Landmarks
por: Rauch, Maximilian, et al.
Publicado: (2022)

Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy
por: Hattingen, Elke, et al.
Publicado: (2013)

Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients
por: Bernatz, Simon, et al.
Publicado: (2021)

Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment
por: Forster, Marie-Therese, et al.
Publicado: (2022)

Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 Trial
por: Wenger, Katharina J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_12qflvj5jdkqpgs05onmipqr9n